NEW YORK, NY — (Marketwire) — 07/13/12 — TriMarkPublications.com cites in its newly published ” Volume 1: IVD Reagents and Instruments Markets” report that the worldwide IVD market will catapult to $82 billion by 2017. For more information, visit: .
detects levels of enzymes, sugars, proteins and other substances in the blood to help identify conditions like diabetes, hyperlipidemia and arteriosclerosis during clinical diagnoses and as part of regular health checkups. Over 750 million will be carried out in U.S. hospitals in 2012. The Asia-Pacific region will experience the fastest growth, accounting for 32% of the world market by 2017.
The ” Volume 1: IVD Reagents and Instruments Markets” report covers:
Clinical Laboratory Instrument Markets
Immunochemistry Analyzers
Hematology Analyzers
Microbiology Testing
Serology Testing
Esoteric Testing
Anatomic Pathology
Point of Care Testing
Biotechnology Reagents and Supplies
Automated Instrument Platforms Evolution
The ” Volume 1: IVD Reagents and Instruments Markets” report examines companies manufacturing equipment and supplies in the world. Companies covered include: Abaxis, Abbott, Adaltis, Alfa Wasserman, Beckman Coulter, Becton Dickinson, bioMérieux, Hitachi, Hologic, Horiba, JEOL, MEDTOX, Myriad Genetics, Nova Biomedical, Ortho-Clinical, Roche Diagnostics, Shimadzu, Sysmex, Thermo Fisher, Tosoh and Vital.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK